Brian Miller, MD, MBA, MPH
Preventive Medicine
Public Health
Hospital Medicine
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Brian Miller
Primary Academic Title
Associate Professor of Medicine
Background
Dr. Miller is a practicing hospitalist and health policy analyst. He serves as an Associate Professor of Medicine at the Johns Hopkins University School of Medicine and an Associate Professor (courtesy) at the Johns Hopkins Carey Business School. His research focuses on FDA regulatory policy, payment policy, and healthcare competition policy.
Dr. Miller previously served as a Medical Officer in the Office of New Drugs at the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, where he focused on pre- and post-market safety regulation, including the review and approval of valbenazine, a first-in-class breakthrough new molecular entity. He also served as a Senior Policy Fellow for Health IT at the Federal Communications Commission, in addition to serving as a Special Advisor in the Federal Trade Commission's Office of Policy Planning. At the FTC, he worked on competition policy and served as an in-house physician expert for the Bureau of Competition, assisting in merger review and enforcement in health systems, pharmaceuticals, and retail drug stores, including the FTC's successful action blocking the $7 billion Advocate - NorthShore merger. Prior to the FTC, Dr. Miller was a Fellow at the Centers for Medicare & Medicaid Innovation, where he co-managed the ACO Investment Model, a $114 million project focused on ACOs in rural areas.
He previously served as a member of the Medicare Evidence Development & Coverage Advisory Committee and a consulting expert witness at the FTC. He is currently a Commissioner on the Medicare Payment Advisory Commission.
Centers and Institutes
X (Twitter)
Research Interests
FDA Regulatory Policy, Payment Policy, Healthcare Competition Policy
Research Summary
Dr. Miller's research focuses on the intersection of healthcare and the state: healthcare competition policy, health insurance program design, and the FDA regulation of drugs, devices, and tobacco products. Applied in nature, his research is conducted in partnership with academics, federal regulators, corporations, and policymakers.
Dr. Miller's goal is to understand how competition can drive increased productivity, lower costs, and improve quality in insurance and care delivery markets. Secondly, he explores how merger control policy affects cost, quality, and consumer experience. Finally, he aims to understand how FDA regulatory pathways for drugs, devices, and tobacco products can be redesigned to promote public health and support cost-effective clinical practice.
Selected Publications
- Davis MC, Miller BJ, Kalsi J, Birkner T, Mathis MV. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. The New England Journal of Medicine 2017;376:2503-2506
- Yagi B, Lushniak BD, Miller BJ. “Appropriate for the Protection of the Public Health: Why We Need Electronic Nicotine Delivery System Product Standards.” Food and Drug Law Journal 2023;78(1):16-62.
- Yagi B, Blanks W, Miller BJ. “The 510(k) Third Party Review Program: Promise and Potential.” Journal of Medical Systems 2023;45:93.
- Spear J, Ehrenfeld JM, Miller BJ. “Applications of Artificial Intelligence in Health Care Delivery.” Journal of Medical Systems 2023;47(121).
- Cho T, Gowda V, Schulzrinne H, Miller BJ. “Integrated Devices: A New Regulatory Pathway to Promote Revolutionary Innovation.” Milbank Q. 2024 Jan 22. doi: 10.1111/1468-0009.12692. Epub ahead of print
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
MedStar Georgetown University Medical Center
Residency, Internal Medicine, 2020Johns Hopkins Bloomberg School of Public Health
Residency, General Preventive Medicine and Public Health, 2016Johns Hopkins Bloomberg School of Public Health
Graduate School, MPH, 2015University of North Carolina at Chapel Hill
Graduate School, MBA, 2013Northwestern University Feinberg School of Medicine
Medical Education, MD, 2011Board Certifications
Internal Medicine
American Board of Internal Medicine, 2020Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)